ZA953560B - Tumor localising photosensitising compounds - Google Patents

Tumor localising photosensitising compounds

Info

Publication number
ZA953560B
ZA953560B ZA953560A ZA953560A ZA953560B ZA 953560 B ZA953560 B ZA 953560B ZA 953560 A ZA953560 A ZA 953560A ZA 953560 A ZA953560 A ZA 953560A ZA 953560 B ZA953560 B ZA 953560B
Authority
ZA
South Africa
Prior art keywords
localising
tumor
photosensitising compounds
photosensitising
compounds
Prior art date
Application number
ZA953560A
Other languages
English (en)
Inventor
David Frederick Horrobin
Brenda Elizabeth Reynolds
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA953560B publication Critical patent/ZA953560B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA953560A 1994-05-03 1995-05-03 Tumor localising photosensitising compounds ZA953560B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408746A GB9408746D0 (en) 1994-05-03 1994-05-03 Tumour locallising photosensitising compounds

Publications (1)

Publication Number Publication Date
ZA953560B true ZA953560B (en) 1996-01-11

Family

ID=10754481

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953560A ZA953560B (en) 1994-05-03 1995-05-03 Tumor localising photosensitising compounds

Country Status (11)

Country Link
EP (1) EP0758331A1 (fr)
JP (1) JPH09512544A (fr)
KR (1) KR970702862A (fr)
AU (1) AU2317295A (fr)
CA (1) CA2189435A1 (fr)
GB (1) GB9408746D0 (fr)
NO (1) NO964635L (fr)
NZ (1) NZ284552A (fr)
TW (1) TW397836B (fr)
WO (1) WO1995029915A1 (fr)
ZA (1) ZA953560B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362175B1 (en) * 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
DE19514087A1 (de) * 1995-04-13 1996-10-17 Deutsches Krebsforsch Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein
DE19627164C2 (de) * 1996-07-05 1998-09-24 Deutsches Krebsforsch Herstellung polyether-aufweisender Chlorine und Bakteriochlorine, solche Verbindungen und ihre Verwendung
ES2237146T3 (es) 1998-08-28 2005-07-16 Destiny Pharma Limited Derivados de porfirina, su uso en terapia fotodinamica y dispositivos medicos que los contienen.
GB0005855D0 (en) * 2000-03-10 2000-05-03 Scotia Holdings Plc Compounds for pdt
JP5000050B2 (ja) * 2001-08-31 2012-08-15 浩 前田 抗腫瘍剤及びその製造方法
CN108715591B (zh) * 2018-06-01 2021-04-13 华东理工大学 用作光敏剂的近红外吸收卟啉化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
ATE115864T1 (de) * 1990-05-30 1995-01-15 Deutsches Krebsforsch Polyethersubstituierte tumormittel.

Also Published As

Publication number Publication date
WO1995029915A1 (fr) 1995-11-09
JPH09512544A (ja) 1997-12-16
NZ284552A (en) 1997-12-19
CA2189435A1 (fr) 1995-11-09
AU2317295A (en) 1995-11-29
NO964635D0 (no) 1996-11-01
TW397836B (en) 2000-07-11
NO964635L (no) 1996-11-01
KR970702862A (ko) 1997-06-10
EP0758331A1 (fr) 1997-02-19
GB9408746D0 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
GB2287652B (en) Efficient photodynamic treatment
GB9421709D0 (en) Therapeutic compounds
ZA955644B (en) Therapeutic compounds
IL128115A0 (en) Electromagnetic cardiac biostimulation
GB9417175D0 (en) Radiation shield
ZA9533B (en) Pentolifylline therapy
GB9700939D0 (en) Therapy
GB9303210D0 (en) Cancer treatment
GB9600143D0 (en) Therapeutic compounds
GB9509572D0 (en) Cancer therapy
ZA953560B (en) Tumor localising photosensitising compounds
GB9308166D0 (en) Cancer therapy
GB9703633D0 (en) Cancer therapy
GB2289370B (en) Magnetrons
GB9416932D0 (en) Tumour specific photeoglycan
GB9424578D0 (en) Cancer treatment
ZA949229B (en) Tumor necrosis factor-gamma
IL120901A0 (en) Cancer therapy
GB9701876D0 (en) Cancer therapy
GB9716289D0 (en) Tumour treatment
GB9416632D0 (en) Therapeutic compounds
GB9416629D0 (en) Therapeutic compounds
SI0769017T1 (en) Therapeutic compounds
GB9304024D0 (en) Tumour therapy
GB9605466D0 (en) Therapy